Tegaserod is a 5-HT4 agonist manufactured by Novartis and sold under the
names Zelnorm and Zelmac for the management of irritable bowel syndrome and
NOTE: On March 30, 2007, the FDA notified healthcare professionals and
patients that Novartis had agreed to discontinue marketing tegaserod (Zelnorm)
for the ...
Apr 15, 2016 ... Tegaserod: learn about side effects, dosage, special precautions, and more on
Mar 31, 2016 ... Novartis, the manufacturer of Zelnorm, has notified the FDA that they will no
longer provide Zelnorm (tegaserod maleate) under a treatment ...
Easy to read patient leaflet for tegaserod. Includes indications, proper use,
special instructions, precautions, and possible side effects.
Jun 13, 2005 ... Description, Tegaserod is a 5-HT4 agonist manufactured by Novartis and used
for the management of irritable bowel syndrome and ...
Zelnorm® (tegaserod maleate) tablets contain tegaserod as the hydrogen
maleate salt. As the maleate salt, tegaserod is chemically designated as ...
Apr 1, 2015 ... Tegaserod is a medicine for short term treatment of women who have irritable
bowel syndrome (IBS) with constipation (not enough or hard ...
Tegaserod (Zelnorm®/Zelmac®, Novartis Pharmaceuticals Inc) has a different
mode of action to alosetron and cisapride. It acts as a serotonin 5-HT4 receptor ...
Tegaserod Arzneimittelgruppen · Serotonin-Agonisten · 5-HT4-Agonisten.
Tegaserod ist ein prokinetischer Wirkstoff aus der Gruppe der
Serotoninagonisten zur ...